Hyzetimibe
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02087917)
Timeline
Indications
Studied for
Mechanism of action
- CholesterolSEQUESTERING AGENT
Cholesterol sequestering agent
Chemistry & pharmacology
Loading structure…
SMILES
O=C1[C@H](C/C=C(\CO)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1- Mol. weight
- 421.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297389 ↗
Also known as
- hs-25
- hs-25
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03433196 | Phase 3 | Jun 7, 2016 | Peking University, Zhejiang Hisun Pharmaceutical Co. Ltd. |
| NCT03413462 | Phase 3 | Apr 12, 2016 | Peking University, Zhejiang Hisun Pharmaceutical Co. Ltd. |
| NCT03464682 | Phase 3 | Feb 28, 2015 | Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang University |
| NCT02087917 | Phase 2 | Mar 1, 2014 | Covance, Zhejiang Hisun Pharmaceutical Co. Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Hisun Pharmaceutical Co. Ltd. | For profit | 4 | 4 | 2 | 2014 |
| Peking University | Academic/Hospital | 2 | 0 | 1 | 2016 |
| Covance | For profit | 1 | 0 | 1 | 2014 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1